ambrisentan
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
19 FDA-registered drug labelers
A-S Medication Solutions
Actavis Pharma, Inc.
Apotex Corp.
Aurobindo Pharma Limited
Cipla Ltd.
Cipla USA Inc.
Gilead Sciences, Inc.
Golden State Medical Supply, Inc.
Matrix Pharmacorp Private Limited
Medichem Manufacturing (Malta) Ltd.
MSN Laboratories Private Limited
Mylan Pharmaceuticals Inc.
Quallent Pharmaceuticals Health LLC
Sigmapharm Laboratories, LLC
Sun Pharmaceutical Industries, Inc.
Veranova, L.P.
Zhejiang Huahai Pharmaceutical Co., Ltd.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Ambrisentan
- •Letairis
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS177036-94-1
PubChem CID6918493
DTXSIDDTXSID4046282
FormulaC22H22N2O4
Mol. Weight378.4 g/mol
SMILESCC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
Data Sources
69184932026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/ambrisentan/cids/JSON
Archive: data/sources/pubchem_name/ambrisentan.json
CAS 177036-94-12026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json